Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUB
1426
DELISTED
Cubic Corporation
CUB
| $9.43M | 0.01% |
159,900
-15,500
| -9% | -$873K |
|
|
SIR
1427
DELISTED
SELECT INCOME REIT
SIR
| $9.4M | 0.01% |
850,622
+231,822
| +37% | +$2.53M |
|
1428
Qualcomm
QCOM
$173B
| $9.39M | 0.01% |
146,758
-2,787,286
| -95% | -$169M |
|
1429
Hubbell
HUBB
$26.8B
| $9.39M | 0.01% |
69,400
-193,500
| -74% | -$24.1M |
|
|
AVDL
1430
DELISTED
Avadel Pharmaceuticals
AVDL
| $9.39M | 0.01% |
1,144,600
+320,900
| +39% | +$3.01M |
|
|
INWK
1431
DELISTED
InnerWorkings, Inc.
INWK
| $9.36M | 0.01% |
933,300
+56,300
| +6% | +$604K |
|
1432
Radian Group
RDN
$4.92B
| $9.36M | 0.01% |
453,900
-477,800
| -51% | -$9.85M |
|
1433
Mizuho Financial
MFG
$134B
| $9.35M | 0.01% |
2,569,300
-73,555
| -3% | -$265K |
|
1434
Microchip Technology
MCHP
$42.2B
| $9.32M | 0.01% |
212,056
-2,222,600
| -91% | -$101M |
|
1435
Gran Tierra Energy
GTE
$336M
| $9.29M | 0.01% |
344,130
-35,280
| -9% | -$788K |
|
1436
Enova International
ENVA
$6.52B
| $9.27M | 0.01% |
610,000
-287,894
| -32% | -$4.23M |
|
|
CNCE
1437
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $9.27M | 0.01% |
358,200
-21,700
| -6% | -$437K |
|
1438
Seres Therapeutics
MCRB
$45M
| $9.24M | 0.01% |
45,560
+14,915
| +49% | +$3.06M |
|
|
CDR
1439
DELISTED
Cedar Realty Trust, Inc
CDR
| $9.21M | 0.01% |
229,515
+79,333
| +53% | +$3.08M |
|
|
TEN
1440
Tsakos Energy Navigation Ltd
TEN
$1.23B
| $9.2M | 0.01% |
470,740
-12,720
| -3% | -$274K |
|
|
ARRY
1441
DELISTED
Array Biopharma Inc
ARRY
| $9.12M | 0.01% |
+712,671
| New | +$8.11M |
|
1442
Aecom
ACM
$8.19B
| $9.12M | 0.01% |
245,477
-21,400
| -8% | -$778K |
|
|
FBNK
1443
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $9.11M | 0.01% |
348,400
+21,952
| +7% | +$581K |
|
|
INVX
1444
Innovex International
INVX
$2.15B
| $9.1M | 0.01% |
190,800
+117,828
| +161% | +$5.26M |
|
|
ZAGG
1445
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $9.09M | 0.01% |
492,390
+381,890
| +346% | +$7.14M |
|
|
CLGX
1446
DELISTED
Corelogic, Inc.
CLGX
| $9.06M | 0.01% |
195,986
+1,382
| +0.7% | +$64K |
|
1447
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.33B
| $9.03M | 0.01% |
82,000
+66,100
| +416% | +$7.32M |
|
1448
Bruker
BRKR
$8.83B
| $9.02M | 0.01% |
262,710
+135,000
| +106% | +$4.42M |
|
1449
AngioDynamics
ANGO
$647M
| $9.01M | 0.01% |
541,800
+82,300
| +18% | +$1.4M |
|
|
AMRN
1450
Amarin Corp
AMRN
$299M
| $8.99M | 0.01% |
112,120
-55,331
| -33% | -$3.81M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.